Targeted degradation of extracellular proteins: state of the art and diversity of degrader designsMd. Abdullah Al Mamun, Alexander ChernorudskiyJournal of Hematology & OncologyMay 1, 202510.1186/s13045-025-01703-4Cited by 23SaveCiteExport RISWatch citationsRelated PapersSmall molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment|Cell Death and Disease|2025|16